Table 1 Summary of the control and treatment groups used in the study

From: Lithium as a disease-modifying agent for prion diseases

Treatment

Number of mice

Route

Lithium dose (µg/kg/day)

Vehicle (control)

13

Rectal

0

NP03-lithium

14

Rectal

40

NP03-lithium

14

Rectal

160

Lithium solution

14

Oral

16,000